LINAPIL M XR 1000 (Metformin (1000mg) + Linagliptin (5mg))

Linapil-M XR 1000 Tablet is indicated for the management of Type 2 Diabetes Mellitus, a condition characterized by insufficient insulin production or reduced response to insulin. This leads to high levels of blood sugar as the body’s organs cannot effectively utilize the available insulin. The formulation of Linapil-M XR 1000 includes Linagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor, and Metformin, a Biguanide. Linagliptin functions by inhibiting the DPP-4 enzyme, which is responsible for degrading incretin hormones that play a crucial role in stimulating insulin secretion in response to meals. Additionally, it helps to decrease hepatic glucose production when it is not necessary. Metformin works by reducing glucose synthesis in the liver, slowing glucose absorption in the gastrointestinal tract, and enhancing insulin sensitivity in peripheral tissues. This synergistic effect effectively helps maintain blood sugar levels within a normal range, particularly post-prandially (after meals). It is recommended to take Linapil-M XR 1000 Tablet with food to minimize gastrointestinal discomfort, and dosing should be consistent daily for optimal results. A healthcare provider will determine the appropriate dosage, which may be adjusted based on individual health needs. Abrupt discontinuation can lead to elevated blood sugar levels, increasing the risk of diabetic complications such as retinopathy, nephropathy, and neuropathy. Caution is advised for individuals with a history of Type 1 Diabetes or significant renal or hepatic impairment. Discuss any pre-existing conditions, plans for pregnancy, or breastfeeding with a healthcare professional.